Chengfei Liu

18PUBLICATIONS
45CO-AUTHORS
Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 15, 2026
Glutamate Ionotropic Kainate Receptors as Therapeutic Targets in Enzalutamide-Resistant and Neuroendocrine Prostate Cancer.

|May 05, 2026
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate Cancer.

|Dec 05, 2025
IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer.

Amy R Leslie, Shu Ning, Masuda Sharifi

|Oct 16, 2025
Dynamic Reprogramming of Immune-Related Signaling During Progression to Enzalutamide Resistance in Prostate Cancer.

Pengfei Xu, Huan Qu, Joy C Yang

|Jun 26, 2025
Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate Cancer.

Masuda Sharifi, Cameron M Armstrong, Shu Ning

|Oct 23, 2024
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells.

Zachary A Schaaf, Shu Ning, Amy R Leslie

Pageof 3

Frequent Collaborators

12 joint publications

Allen C Gao

7 joint publications

Shu Ning

7 joint publications

Zachary A Schaaf

7 joint publications

Amy R Leslie